GlassScriptPhysician profile
David A Palma
NPI 1083875462
$3,356.26
in general payments reported to CMS, 2019-2025
24 companies · $432 in 2025
The $432 reported for 2025 was more than what 76% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $173 · 2021: $483 · 2022: $1,212 · 2023: $224 · 2024: $544 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,265.84 | 2019-2025 | Proclaim, Axium, Eterna |
| Bioventus LLC | $457.83 | 2019-2022 | |
| Medtronic, INC. | $268.02 | 2021-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System, Intellis Adaptivestim |
| Valinor Pharma, LLC | $167.29 | 2024-2025 | Movantik |
| Vertex Pharmaceuticals Incorporated | $154.89 | 2024-2025 | |
| Boston Scientific Corporation | $153.59 | 2019-2025 | Intracept |
| Endo Pharmaceuticals INC. | $139.67 | 2020-2024 | Xiaflex |
| Nalu Medical, INC. | $134.80 | 2021-2022 | |
| Painteq LLC | $98.30 | 2021-2024 | Painteq |
| Relievant Medsystems, INC. | $72.10 | 2021-2023 | Intracept |
| Endo USA, INC. | $64.65 | 2024-2025 | Xiaflex |
| Medtronic USA, INC. | $62.90 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $42.93 | 2025 | Purified Cortrophin Gel |
| Hydrocision, INC. | $39.66 | 2024 | Tenjet |
| Ucb, INC. | $33.09 | 2025 | Bimzelx |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $32.00 | 2019 | |
| Ethicon US, LLC | $29.12 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.47 | 2019 | |
| Baudax Bio INC. | $23.13 | 2021 | |
| Averitas Pharma INC. | $22.54 | 2025 | Qutenza |
| Smith+Nephew, INC. | $20.04 | 2025 | Pico |
| Depuy Synthes Sales INC. | $19.66 | 2023 | Orthovisc, Monovisc |
| Vertos Medical, INC. | $16.69 | 2023 | Mild Device Kit |
| Convatec INC. | $14.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Palma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.